Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tibbitts, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tibbitts, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Issues Related to the Use of Canines in Toxicologic Pathology—Issues With Pharmacokinetics and Metabolism

Jay Tibbitts

XOMA (US) LLC, Berkeley, California 94710, tibbitts{at}xoma.com

The dog is a commonly used animal model by virtue of its size, well-characterized physiology, and ease of handling. For these reasons and others, dogs are also useful in pharmacokinetic and metabolism studies during the development of both human and veterinary pharmaceutical products. In comparison with humans, or with other animals, dogs have some unique physiologic attributes that can affect the disposition of drugs. Species differences in gastrointestinal physiology, metabolism, renal function, and protein binding can affect the correlation of the pharmacokinetics and toxicology of dogs with those of other species. With the use of relevant examples, this article will provide an introduction to characteristics of dog physiology and their impact on pharmacokinetics, metabolism, drug disposition, toxicity, and dose selection.

Key Words: Pharmacokinetics • dog • metabolism • P450 • excretion • absorption • protein binding.

References

  • Allen A., Newton J., Oliver L., Jordan N., Strugala V., Pearson JP, Dettmar PW (1997). Mucus and H. pylori. J Physiol Pharmacol 48: 297—305.[Web of Science][Medline] [Order article via Infotrieve]
  • Amacher DE, Schomaker SJ, Burkhardt JE (2001). The relationship among microsomal enzyme induction, liver weight and histological change in beagle dog toxicology studies. Food Chem Toxicol 39: 817—825.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Mizobe M., Kohno K., Samejima M. (1986). Bioavailability of sugar-coated tablets of thiamine disulfide in humans. II. Correlation with bioavailability in beagle dogs. Chem Pharm Bull (Tokyo) 34: 292—300.[Medline] [Order article via Infotrieve]
  • Belpaire FM, De Rick A., Dello C., Fraeyman N., Bogaert MG (1987). Alpha 1-acid glycoprotein and serum binding of drugs in healthy and diseased dogs. J Vet Pharmacol Ther 10: 43—48.[Web of Science][Medline] [Order article via Infotrieve]
  • Blaisdell J., Goldstein JA, Bai SA (1998). Isolation of a new canine cytochrome P450 CDNAfromthe cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression. Drug Metab Dispos 26: 278—283.[Abstract/Free Full Text]
  • Bogaards JJ, Bertrand M., Jackson P., Oudshoorn MJ, Weaver RJ, van Bladeren PJ, Walther B. (2000). Determining the best animal model for human cytochrome P450 activities: A comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30: 1131—1152.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13: 407—484.[Free Full Text]
  • Chauret N., Gauthier A., Martin J., Nicoll-Griffith DA (1997). In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab Dispos 25: 1130—1136.[Abstract/Free Full Text]
  • Chiou WL, Barve A. (1998). Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res 15: 1792— 1795.
  • Chiou WL, Jeong HY, Chung SM, Wu TC (2000). Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharm Res 17: 135—140.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chiu SH, Huskey SW (1998). Species differences in N-glucuronidation. Drug Metab Dispos 26: 838—847.[Abstract/Free Full Text]
  • Collins JM (2001). Inter-species differences in drug properties. Chem Biol Interact 134: 237—242.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Court MH, Hay-Kraus BL, Hill DW, Kind AJ, Greenblatt DJ (1999). Propofol hydroxylation by dog liver microsomes: Assay development and dog breed differences. Drug Metab Dispos 27: 1293—1299.[Abstract/Free Full Text]
  • Davies B., Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10: 1093—1095.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Dedrick RL, Forrester DD, Cannon JN, el-Dareer SM, Mellett LB (1973). Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine (ARA-C) deamination in several species. Biochem Pharmacol 22: 2405— 2417.
  • Dello CP, Belpaire FM, De Rick A., Fraeyman NH (1988). Influence of inflammation on serum concentration, molecular heterogeneity and drug binding properties of canine alpha-1-acid glycoprotein. J Vet Pharmacol Ther 11: 71—76.[Web of Science][Medline] [Order article via Infotrieve]
  • Dello CP, Belpaire FM, Kint JA, Fraeyman NH (1987). Dog alpha-1-acid glycoprotein: Purification and biochemical characterization. J Pharmacol Methods 18: 335—345.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Dressman JB (1986). Comparison of canine and human gastrointestinal physiology. Pharm Res 3: 123—131.[CrossRef][Web of Science]
  • Eberhart DC, Gemzik B., Halvorson MR, Parkinson A. (1991). Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin. Mol Pharmacol 40: 859—867.[Abstract]
  • Edwards NA( 1975). Scaling of renal functions in mammals. CompBiochem Physiol A 52: 63—66.
  • Emas S., Grossman MI (1967). Comparison of gastric secretion in conscious dogs and cats. Gastroenterology 52: 29—34.[Medline] [Order article via Infotrieve]
  • Ericzon BG, Todo S., Lynch S., Kam I., Ptachcinski RJ, Burckart GJ, Van Thiel DH, Starzl TE, Venkataramanan R. (1987). Role of bile and bile salts on cyclosporine absorption in dogs. Transplant Proc 19: 1248— 1249.
  • He YL, Murby S., Warhurst G., Gifford L., Walker D., Ayrton J., Eastmond R., Rowland M. (1998). Species differences in size discrimination in the para-cellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides. J Pharm Sci 87: 626—633.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hinderling PH, Dilea C., Koziol T., Millington G. (1993). Comparative kinetics of sematilide in four species. Drug Metab Dispos 21: 662— 669.
  • Hinkle KL, Samuelson LC (1999). Lessons from genetically engineered animal models. III. Lessons learned from gastrin gene deletion in mice. Am J Physiol 277:G500—G505.[Web of Science][Medline] [Order article via Infotrieve]
  • Hojo T., Ohno R., Shimoda M., Kokue E. (2002). Enzyme and plasma protein induction by multiple oral administrations of phenobarbital at a therapeutic dosage regimen in dogs. J Vet Pharmacol Ther 25: 121—127.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jayyosi Z., Muc M., Erick J., Thomas PE, Kelley M. (1996). Catalytic and immunochemical characterization of cytochrome P450 isozyme induction in dog liver. Fundam Appl Toxicol 31: 95—102.[Medline] [Order article via Infotrieve]
  • Kamiya A., Okumura K., Hori R. ( 1983). Quantitative investigation on renal handling of drugs in rabbits, dogs, and humans. J Pharm Sci 72: 440— 443.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kararli TT (1995). Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16: 351—380.[Web of Science][Medline] [Order article via Infotrieve]
  • Katsuyama T., Ota H., Ishii K., Nakayama J., Kanai M., Akamatsu T., Sugiyama A. (1991). Histochemical characterization of gastric mucin-secreting cells and the surface gel layer. In: Gastrointestinal Function, Matsuo Y (ed). Elsevier Science Publishers BV, Amsterdam, pp 145—165.
  • Kawalek JC, el Said KR (1990). Maturational development of drug-metabolizing enzymes in dogs. Am J Vet Res 51: 1742—1745.[Web of Science][Medline] [Order article via Infotrieve]
  • Kim SH, Kim WB, Lee MG (1998). Interspecies pharmacokinetic scaling of a new carbapenem, DA-1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics. Biopharm Drug Dispos 19: 231—235.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Korytko PJ, Casey AC, Bush B., Quimby FW (1999). Induction of hepatic cytochromes P450 in dogs exposed to a chronic low dose of polychlorinated biphenyls. Toxicol Sci 47: 52—61.[Abstract/Free Full Text]
  • Lawrence GS, Gobas FA (1997). A pharmacokinetic analysis ofinterspecies extrapolation in dioxin risk assessment. Chemosphere 35: 427—452.[Medline] [Order article via Infotrieve]
  • Lin JH (1995). Species similarities and differences in pharmacokinetics. Drug Metab Dispos 23: 1008—1021.[Abstract]
  • Lin JH, Chen IW, deLuna FA, Hichens M. (1993). Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats. J Pharmacol Exp Ther 267: 670—675.[Abstract/Free Full Text]
  • Lin JH, Chen IW, Ulm EH (1989). Dose-dependent kinetics of cilastatin in laboratory animals. Drug Metab Dispos 17: 426—432.[Abstract]
  • Lin JH, deLuna FA, Ulm EH, Tocco DJ (1990). Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist. Drug Metab Dispos 18: 484—487.[Abstract]
  • Lipka E., Lee ID, Langguth P., Spahn-Langguth H., Mutschler E., Amidon GL (1995). Celiprolol double-peak occurrence and gastric motility: Nonlinear mixed effects modeling of bioavailability data obtained in dogs. J Pharmacokinet Biopharm 23: 267—286.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lower GM Jr, Bryan GT (1973). Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. Biochem Pharmacol 22: 1581—1588.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lu C., Li AP (2001). Species comparison in P450 induction: Effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem Biol Interact 134: 271—281.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mesfin GM, Higgins MJ, Robinson FG, Zhong WZ (1996). Relationship between serum concentrations, hemodynamic effects, and cardiovascular lesions in dogs treated with minoxidil. Toxicol Appl Pharmacol 140: 337— 344.
  • Miller TA (1988). Gastroduodenal mucosal defense: Factors responsible for the ability of the stomach and duodenum to resist injury. Surgery 103: 389—397.[Web of Science][Medline] [Order article via Infotrieve]
  • Mithani SD, Bakatselou V., TenHoor CN, Dressman JB (1996). Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm Res 13: 163—167.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nishibe Y., Hirata M. (1993). Effect of phenobarbital and other model inducers on cytochrome P450 isoenzymes in primary culture of dog hepatocytes. Xenobiotica 23:681—692.[Web of Science][Medline] [Order article via Infotrieve]
  • Ohmori S., Taniguchi T., Rikihisa T., Kanakubo Y., Kitada M. (1993). Species differences of testosterone 16-hydroxylases in liver microsomes of guinea pig, rat and dog. Xenobiotica 23: 419—426.[Web of Science][Medline] [Order article via Infotrieve]
  • Okazaki O., Kurata T., Hakusui H., Tachizawa H. (1992). Species-related stereoselective disposition of ofloxacin in the rat, dog and monkey. Xenobiotica 22: 439—450.[Web of Science][Medline] [Order article via Infotrieve]
  • Paulson SK, Engel L., Reitz B., Bolten S., Burton EG, Maziasz TJ, Yan B., Schoenhard GL (1999). Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab Dispos 27: 1133—1142.[Abstract/Free Full Text]
  • Petruska JM, Beattie JG, Stuart BO, Pai S., Walters KM, Banks CM, Lulham GW, Mirro EJ (1997). Cardiovascular effects after inhalation of large doses of albuterol dry powder in rats, monkeys, and dogs: A species comparison. Fundam Appl Toxicol 40: 52—62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Puigdemont A., Arboix M., Gaspari F., Bortolotti A., Bonati M. (1989). In vitro plasma protein binding of propafenone and protein profile in eight mammalian species. Res Commun Chem Pathol Pharmacol 64: 435—440.[Web of Science][Medline] [Order article via Infotrieve]
  • Roussel F., Duignan DB, Lawton MP, Obach RS, Strick CA, Tweedie DJ (1998). Expression and characterization of canine cytochrome P450 2D15. Arch Biochem Biophys 357: 27—36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rowland M., Tozer TN (1989). Clinial Pharmacokinetics: Concepts and Applications. Lea & Febiger, Philadelphia, PA.
  • Sahi J., Reyner EL, Bauman JN, Gueneva-Boucheva K., Burleigh JE, Thomas VH (2002). The effect of bergamottin on diazepam plasma levels and P450 enzymes in beagle dogs. Drug Metab Dispos 30: 135—140.[Abstract/Free Full Text]
  • Savidge RD, Bui KH, Birmingham BK, Morse JL, Spreen RC (1998). Metabolism and excretion of zafirlukast in dogs, rats, and mice. Drug Metab Dispos 26: 1069—1076.[Abstract/Free Full Text]
  • Sawada Y., Hanano M., Sugiyama Y., Iga T. (1984). Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals. J Pharmacokinet Biopharm 12: 241—261.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sharer JE, Shipley LA, Vandenbranden MR, Binkley SN, Wrighton SA (1995). Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metab Dispos 23: 1231—1241.[Abstract]
  • Shiba K., Saito A., Shimada J., Hori S., Kaji M., Miyahara T., Kusajima H., Kaneko S., Saito S., Ooie T., Uchida H. (1990). Renal handling of fleroxacin in rabbits, dogs, and humans. Antimicrob Agents Chemother 34: 58—64.[Abstract/Free Full Text]
  • Shimada J., Yamaji T., Ueda Y., Uchida H., Kusajima H., Irikura T. (1983). Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans. Antimicrob Agents Chemother 23: 1—7.[Abstract/Free Full Text]
  • Shimada T., Mimura M., Inoue K., Nakamura S., Oda H., Ohmori S., Yamazaki H. (1997). Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Arch Toxicol 71: 401—408.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Shirota FN, Nagasawa HT, Kwon CH, DeMaster EG (1984). N-acetylcyanamide, the major urinary metabolite of cyanamide in rat, rabbit, dog, and man. Drug Metab Dispos 12: 337—344.[Abstract]
  • Tanaka E., Narisawa C., Nakamura H., Sawa Y., Etoh H., Tadano K., Horie T., Ohkawa H., Misawa S. (1998). Changes in the enzymatic activities of beagle liver during maturation as assessed both in vitro and in vivo. Xenobiotica 28: 795—802.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsoi C., Falany CN, Morgenstern R., Swedmark S. (2001). Identification of a new subfamily of sulphotransferases: Cloning and characterization of canine SULT1D1. Biochem J 356: 891—897.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsoi C., Morgenstern R., Swedmark S. (2002). Canine sulfotransferase SULT1A1: Molecular cloning, expression, and characterization. Arch Biochem Biophys 401: 125—133.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsunekawa Y., Hasegawa T., Nadai M., Takagi K., Nabeshima T. (1992). Interspecies differences and scaling for the pharmacokinetics of xanthine derivatives. J Pharm Pharmacol 44: 594—599.[Web of Science][Medline] [Order article via Infotrieve]
  • Weingarten HP, Powley TL (1980). A new technique for the analysis of phasic gastric acid responses in the unanesthetized rat. Lab Anim Sci 30: 673—680.[Web of Science][Medline] [Order article via Infotrieve]
  • Yang JT, Morris M., Wong KK, Kucharczyk N., Sofia RD (1992). Felbamate metabolism in pediatric and adult beagle dogs. Drug Metab Dispos 20: 84—88.[Abstract]
  • Zhang L., Fitzloff JF, Engel LC, Cook CS ( 2001). Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide. Xenobiotica 31: 73—83.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 31, No. 1 suppl, 17-24 (2003)
DOI: 10.1080/01926230390174896
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
C. W. Locuson, B. T. Ethell, M. Voice, D. Lee, and K. L. Feenstra
Evaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 Reductase
Drug Metab. Dispos., March 1, 2009; 37(3): 457 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J.-P. H. T. M. Ploemen, H. Kramer, E. I. Krajnc, and I. Martin
The Use of Toxicokinetic Data in Preclinical Safety Assessment: A Toxicologic Pathologist Perspective
Toxicol Pathol, October 1, 2007; 35(6): 834 - 837.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. R. Foster
Spontaneous and Drug-Induced Hepatic Pathology of the Laboratory Beagle Dog, the Cynomolgus Macaque and the Marmoset
Toxicol Pathol, January 1, 2005; 33(1): 63 - 74.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tibbitts, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tibbitts, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?